Short answer · Medically reviewed summary · Last updated: 2026-05-08
Cohen Syndrome is classified under the ICD-10-CM code Q87.89 (Other specified congenital malformation syndromes, not elsewhere classified) and the ICD-9-CM code 759.89 (Other specified congenital anomalies). Because Cohen Syndrome is a rare genetic disorder, it does not have a unique, disease-specific code in either system, necessitating the use of these broader classifications for billing and medical record documentation. What is the clinical significance of Cohen Syndrome? Cohen Syndrome is a rare, multisystem genetic disorder characterized by non-progressive intellectual disability, microcephaly, distinct facial features, and progressive retinal dystrophy.
3 people with Cohen Syndrome have shared their first-person experience on this question at DiseaseMaps.
Cohen Syndrome is classified under the ICD-10-CM code Q87.89 (Other specified congenital malformation syndromes, not elsewhere classified) and the ICD-9-CM code 759.89 (Other specified congenital anomalies). Because Cohen Syndrome is a rare genetic disorder, it does not have a unique, disease-specific code in either system, necessitating the use of these broader classifications for billing and medical record documentation.
Cohen Syndrome is a rare, multisystem genetic disorder characterized by non-progressive intellectual disability, microcephaly, distinct facial features, and progressive retinal dystrophy. Clinicians often observe hypotonia and joint laxity in early childhood. Managing Cohen Syndrome requires a multidisciplinary team, as the condition impacts vision, motor development, and social-emotional growth throughout a patient's lifespan.
Diagnosis of Cohen Syndrome is typically confirmed through molecular genetic testing, specifically identifying pathogenic variants in the VPS13B gene (formerly COH1). While there is no cure, care focuses on supportive therapies:
Yes, Cohen Syndrome is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the mutated VPS13B gene—one from each carrier parent—to express the condition. Parents of an affected child have a 25% recurrence risk for each subsequent pregnancy.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.